tiprankstipranks

Catalyst Pharmaceuticals initiated with an Outperform at Baird

Baird analyst Joel Beatty initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1